Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Neptra
Active substances:
Mometasone+Florfenicol+Terbinafine
Estonian, English, Latin
ATC code: QS02CA89
Dosage form: ear drops, solution
Strength: 2,2mg+16,7mg+16,7mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Indication: For the treatment of acute canine otitis externa or acute exacerbations of recurrent otitis caused by mixed infections of susceptible strains of bacteria sensitive to florfenicol (Staphylococcus pseudintermedius) and fungi sensitive to terbinafine (Malassezia pachydermatis)
Safety features: No
Marketing authorization holder: Bayer Animal Health GmbH 
Marketing authorization number: EU/2/19/246 
Marketing authorization issued on: December 10, 2019 
Marketing authorization expires on: December 12, 2024 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1809389  Neptra  ear drops, solution  2,2mg +16,7mg +16,7mg 1ml 1ml 2TK  Prescription      22.02.2024     
1809390  Neptra  ear drops, solution  2,2mg +16,7mg +16,7mg 1ml 1ml 10TK  Prescription      23.05.2024     
1809402  Neptra  ear drops, solution  2,2mg +16,7mg +16,7mg 1ml 1ml 20TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere